Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD) Additionally, Canntab’s application is currently “In Progress” to obtain a Cannabis Licence (Processing- Standard, Federal […]
Multi-Center Phase III trial planned for 2019
[…]
PRINCETON, NJ – May 14, 2019 – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical […]
Key Company Highlights:*Providing Agricultural and Cultivation Solutions to Farmers*Infrastructure Maintenance and Cleaning Solutions to Mining sector*Preventing Water Contamination*Retail Opportunities INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street this is Juan Costello, Senior Analyst with the […]
INTERVIEW HIGHLIGHTS: *Two Pivotal Phase III studies for T-cell Lymphoma and Oral mucositis *Enrollment milestone for SGX942 *Upcoming interim analysis for SGX942 in September *Top-line final results for CTCL expected in 1Q 2020 INTERVIEW SUMMARY: […]
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]
THIS INTERVIEW HAS EXPIRED
Company provides Q1 2019 update and guidance. Upcoming interview with WSA. […]
Following a 3-month treatment, significant Hb1c Reduction was observed with administration of a single dose of Insugin two times a day […]
DALLAS, TX, April 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NaturalShrimp, Inc. (SHMP) announced today that their order for two additional EC shrimp water treatment systems have arrived at their Lacoste, Texas, facility, near […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com